Discover
SLDB
Solid Biosciences Inc.
9.20
5 x 8.81
1 x 10.90
bid
ask
+
0.12
1.32%
100 @ 04:00 PM
9.46 +0.26 (2.87%)
| Ytd | 63.12% | |
| 1y | 49.11% |
8.73
day range
9.35
3.93
52 week range
11.15
| Open | 8.88 | Prev Close | 9.08 | Low | 8.73 | High | 9.35 | Mkt Cap | 905.74M |
| Vol | 751.95K | Avg Vol | 1.66M | EPS | -1.88 | P/E | -4.89 | Forward P/E | -5.69 |
| Beta | 2.36 | Short Ratio | 9.40 | Inst. Own | 104.56% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 8.61 | 200-d Avg | 6.92 | 1yr Est | 17.38 |
| Income Statement | |||
| Operating Expenses | 57.38M | ||
| Research and Development Expense | 44.27M | ||
| Selling, General and Administrative Expense | 13.12M | ||
| Operating Income | -57.38M | ||
| Net Income | -54.80M | ||
| Net Income Common Stock | -54.80M | ||
| Net Income Common Stock (USD) | -54.80M | ||
| Consolidated Income | -54.80M | ||
| Earnings per Basic Share | -0.38 | ||
| Earnings per Basic Share (USD) | -0.38 | ||
| Earnings per Diluted Share | -0.38 | ||
| Earning Before Interest & Taxes (EBIT) | -54.80M | ||
| Earning Before Interest & Taxes (USD) | -54.80M | ||
| Weighted Average Shares | 143.69M | ||
| Weighted Average Shares Diluted | 143.69M | ||
| Balance Sheet | |||
| Cash and Equivalents | 160.03M | ||
| Cash and Equivalents (USD) | 160.03M | ||
| Investments | 218.99M | ||
| Investments Current | 218.28M | ||
| Investments Non-Current | 708.00K | ||
| Current Assets | 395.11M | ||
| Property, Plant & Equipment Net | 24.63M | ||
| Total Assets | 420.58M | ||
| Debt Current | 2.23M | ||
| Total Debt | 20.16M | ||
| Current Liabilities | 28.58M | ||
| Debt Non-Current | 17.92M | ||
| Total Liabilities | 46.51M | ||
| Accumulated Retained Earnings (Deficit) | -1.07B | ||
| Accumulated Other Comprehensive Income | -113.00K | ||
| Shareholders Equity | 374.08M | ||
| Shareholders Equity (USD) | 374.08M | ||
| Assets Non-Current | 25.47M | ||
| Total Debt (USD) | 20.16M | ||
| Liabilities Non-Current | 17.92M | ||
| Trade and Non-Trade Payables | 4.36M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.02M | ||
| Net Cash Flow from Financing | 48.47M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -137.71M | ||
| Capital Expenditure | -150.00K | ||
| Issuance (Purchase) of Equity Shares | 48.47M | ||
| Net Cash Flow from Investing | -133.59M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -133.44M | ||
| Net Cash Flow from Operations | -52.59M | ||
| Share Based Compensation | 5.62M | ||